Jupiter Acquisition Corporation (JAQCU) Prices $150M IPO
by Nicholas Alan Clayton on 2021-08-13 at 6:19am

Jupiter Acquisition Corporation announced the pricing of its $150 million IPO today and its units are expected to begin trading on the Nasdaq under the ticker symbol “JAQCU” Friday, August 13.

The new SPAC intends to find a combination partner in the consumer or TMT sectors. It is led by Chairman, CEO and CFO James N. Hauslein, Vice Chairman James N. Clarke, COO James Thayer, and President Gaurav Burman.

Total SPAC deal count for 2021 year-to-date is now 411. The offering is anticipated to close on Tuesday, August 17.


Nomura Securities International Inc., Brookline Capital Markets, and Ladenburg Thalmann & Co. are serving as the joint book-running managers for the offering. Greenberg Traurig and Paul Hastings LLP, were Issuer’s Counsel and Underwriter’s Counsel, respectively. Marcum LLP acted as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved